Clinical Trial Update: Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports results from a study evaluating patient-reported outcomes with armodafinil in adults with narcolepsy or obstructive s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea

Drugs mentioned

• Armodafinil (armodafinil)

Snippet

Sponsor: Cephalon | Conditions: Excessive Daytime Sleepiness, Narcolepsy | Phase 3 | Status: COMPLETED | Results posted: 2010-06-25